The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT).
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT).
- Published In:
- GeroScience, 45(6), 3529-3548 (2023)
- Authors:
- Pharaoh, Gavin, Kamat, Varun, Kannan, Sricharan, Stuppard, Rudolph S, Whitson, Jeremy, Martín-Pérez, Miguel, Qian, Wei-Jun, MacCoss, Michael J, Villén, Judit, Rabinovitch, Peter, Campbell, Matthew D, Sweet, Ian R, Marcinek, David J
- Database ID:
- RPEP-07274
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07274APA
Pharaoh, Gavin; Kamat, Varun; Kannan, Sricharan; Stuppard, Rudolph S; Whitson, Jeremy; Martín-Pérez, Miguel; Qian, Wei-Jun; MacCoss, Michael J; Villén, Judit; Rabinovitch, Peter; Campbell, Matthew D; Sweet, Ian R; Marcinek, David J. (2023). The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT).. GeroScience, 45(6), 3529-3548. https://doi.org/10.1007/s11357-023-00861-y
MLA
Pharaoh, Gavin, et al. "The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT).." GeroScience, 2023. https://doi.org/10.1007/s11357-023-00861-y
RethinkPeptides
RethinkPeptides Research Database. "The mitochondrially targeted peptide elamipretide (SS-31) im..." RPEP-07274. Retrieved from https://rethinkpeptides.com/research/pharaoh-2023-the-mitochondrially-targeted-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.